These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys. Recasens A; Dehay B; Bové J; Carballo-Carbajal I; Dovero S; Pérez-Villalba A; Fernagut PO; Blesa J; Parent A; Perier C; Fariñas I; Obeso JA; Bezard E; Vila M Ann Neurol; 2014 Mar; 75(3):351-62. PubMed ID: 24243558 [TBL] [Abstract][Full Text] [Related]
4. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein. Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656 [TBL] [Abstract][Full Text] [Related]
6. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease. Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577 [TBL] [Abstract][Full Text] [Related]
9. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration. Jimenez-Ferrer I; Jewett M; Tontanahal A; Romero-Ramos M; Swanberg M Neurobiol Dis; 2017 Oct; 106():279-290. PubMed ID: 28736195 [TBL] [Abstract][Full Text] [Related]
10. Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease. Kim S; Kwon SH; Kam TI; Panicker N; Karuppagounder SS; Lee S; Lee JH; Kim WR; Kook M; Foss CA; Shen C; Lee H; Kulkarni S; Pasricha PJ; Lee G; Pomper MG; Dawson VL; Dawson TM; Ko HS Neuron; 2019 Aug; 103(4):627-641.e7. PubMed ID: 31255487 [TBL] [Abstract][Full Text] [Related]
11. Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Janezic S; Threlfell S; Dodson PD; Dowie MJ; Taylor TN; Potgieter D; Parkkinen L; Senior SL; Anwar S; Ryan B; Deltheil T; Kosillo P; Cioroch M; Wagner K; Ansorge O; Bannerman DM; Bolam JP; Magill PJ; Cragg SJ; Wade-Martins R Proc Natl Acad Sci U S A; 2013 Oct; 110(42):E4016-25. PubMed ID: 24082145 [TBL] [Abstract][Full Text] [Related]
12. Decreased AQP4 Expression Aggravates ɑ-Synuclein Pathology in Parkinson's Disease Mice, Possibly via Impaired Glymphatic Clearance. Cui H; Wang W; Zheng X; Xia D; Liu H; Qin C; Tian H; Teng J J Mol Neurosci; 2021 Dec; 71(12):2500-2513. PubMed ID: 33772424 [TBL] [Abstract][Full Text] [Related]
13. Propagation of pathological α-synuclein in marmoset brain. Shimozawa A; Ono M; Takahara D; Tarutani A; Imura S; Masuda-Suzukake M; Higuchi M; Yanai K; Hisanaga SI; Hasegawa M Acta Neuropathol Commun; 2017 Feb; 5(1):12. PubMed ID: 28148299 [TBL] [Abstract][Full Text] [Related]
14. Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils. Patterson JR; Duffy MF; Kemp CJ; Howe JW; Collier TJ; Stoll AC; Miller KM; Patel P; Levine N; Moore DJ; Luk KC; Fleming SM; Kanaan NM; Paumier KL; El-Agnaf OMA; Sortwell CE Neurobiol Dis; 2019 Oct; 130():104525. PubMed ID: 31276792 [TBL] [Abstract][Full Text] [Related]
15. PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats. Thomsen MB; Ferreira SA; Schacht AC; Jacobsen J; Simonsen M; Betzer C; Jensen PH; Brooks DJ; Landau AM; Romero-Ramos M Neurobiol Dis; 2021 Feb; 149():105229. PubMed ID: 33352233 [TBL] [Abstract][Full Text] [Related]
16. Structurally distinct α-synuclein fibrils induce robust parkinsonian pathology. Hayakawa H; Nakatani R; Ikenaka K; Aguirre C; Choong CJ; Tsuda H; Nagano S; Koike M; Ikeuchi T; Hasegawa M; Papa SM; Nagai Y; Mochizuki H; Baba K Mov Disord; 2020 Feb; 35(2):256-267. PubMed ID: 31643109 [TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate. Faustini G; Longhena F; Bruno A; Bono F; Grigoletto J; La Via L; Barbon A; Casiraghi A; Straniero V; Valoti E; Costantino G; Benfenati F; Missale C; Pizzi M; Spillantini MG; Bellucci A Neurobiol Dis; 2020 May; 138():104789. PubMed ID: 32032728 [TBL] [Abstract][Full Text] [Related]
18. Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions. Stoyka LE; Arrant AE; Thrasher DR; Russell DL; Freire J; Mahoney CL; Narayanan A; Dib AG; Standaert DG; Volpicelli-Daley LA Neurobiol Dis; 2020 Feb; 134():104708. PubMed ID: 31837424 [TBL] [Abstract][Full Text] [Related]
19. Geraniol attenuates α-synuclein expression and neuromuscular impairment through increase dopamine content in MPTP intoxicated mice by dose dependent manner. Rekha KR; Selvakumar GP; Santha K; Inmozhi Sivakamasundari R Biochem Biophys Res Commun; 2013 Nov; 440(4):664-70. PubMed ID: 24103762 [TBL] [Abstract][Full Text] [Related]
20. Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains. Longhena F; Faustini G; Varanita T; Zaltieri M; Porrini V; Tessari I; Poliani PL; Missale C; Borroni B; Padovani A; Bubacco L; Pizzi M; Spano P; Bellucci A Brain Pathol; 2018 Nov; 28(6):875-888. PubMed ID: 29330884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]